Reimbursement Intelligence, based in Elk Grove Village, IL, is a leading market access platform and advisory firm that specializes in preparing healthcare companies for success in the value-based economy. With a focus on providing insights, data-driven tools, and solution-oriented expertise, they help their clients gain a competitive advantage in the biopharma and payer market. Their wide range of strategic and operational market access solutions, along with their innovative products, support their clients in maximizing the potential of their market access teams.
Real Endpoints, a division of Reimbursement Intelligence, offers cutting-edge technology and AI platforms such as RE Assist, which provides real-time foundation fund information to Medicare patients in need of deductible and copay assistance. They have also collaborated with bluebird bio to scale the delivery of a first-of-its-kind value-based contract for gene therapy, removing economic uncertainties and expanding patient access. Real Endpoints is at the forefront of the gene therapy industry, bringing together senior executives to discuss best practices in the commercialization of this novel class of therapies, including innovative contracting approaches and cost-effectiveness strategies.
Generated from the website